Telmisartan overdosage: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Telmisartan}} {{CMG}}; {{AE}} {{SS}} ==Overdosage== Limited data are available with regard to overdosage in humans. The most likely manifestation of overdosage w..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overdosage== | ==Overdosage== | ||
Limited data are available with regard to overdosage in humans. The most likely manifestation of overdosage with MICARDIS tablets would be [[hypotension]], [[dizziness]] and [[tachycardia]]; [[bradycardia]] could occur from [[parasympathetic]] (vagal) stimulation. If symptomatic [[hypotension]] should occur, supportive treatment should be instituted. Telmisartan is not removed by [[hemodialysis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MICARDIS (TELMISARTAN) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb | publisher = | date = | accessdate = 24 February 2014 }}</ref | Limited data are available with regard to overdosage in humans. The most likely manifestation of overdosage with MICARDIS tablets would be [[hypotension]], [[dizziness]] and [[tachycardia]]; [[bradycardia]] could occur from [[parasympathetic]] (vagal) stimulation. If symptomatic [[hypotension]] should occur, supportive treatment should be instituted. Telmisartan is not removed by [[hemodialysis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MICARDIS (TELMISARTAN) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb | publisher = | date = | accessdate = 24 February 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 16:12, 24 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Overdosage
Limited data are available with regard to overdosage in humans. The most likely manifestation of overdosage with MICARDIS tablets would be hypotension, dizziness and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation. If symptomatic hypotension should occur, supportive treatment should be instituted. Telmisartan is not removed by hemodialysis.[1]
References
- ↑ "MICARDIS (TELMISARTAN) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]". Retrieved 24 February 2014.